Evidence map›Paper›PMID 38038252›Full record

ArticleNucleic acids research2024

DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaks.

Lia M Pinto, Alexandros Pailas, Max Bondarchenko, Abhishek Bharadwaj Sharma, Katrin Neumann, Anthony J Rizzo, Céline Jeanty, Nathalie Nicot, Carine Racca, Mindy K Graham and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 4 countries.

Lia M PintoDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.
Alexandros PailasDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.
Max BondarchenkoDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.
Abhishek Bharadwaj SharmaDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.ORCID 0000-0003-2554-1025
Katrin NeumannDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.
Anthony J RizzoDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Céline JeantyDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.
Nathalie NicotTranslational Medicine Operations Hub, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg.
Carine RaccaInstitut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), 31077 Toulouse Cedex 4, France.
Mindy K GrahamDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Catherine NaughtonMedical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh EH4 1QY, UK.
Yaqun LiuInstitut Curie, PSL Research University, CNRS UMR3244, Dynamics of Genetic Information, Sorbonne Université, 75248 Paris Cedex 05, France.
Chun-Long ChenInstitut Curie, PSL Research University, CNRS UMR3244, Dynamics of Genetic Information, Sorbonne Université, 75248 Paris Cedex 05, France.ORCID 0000-0002-4795-0295
Paul J MeakinDiscovery & Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds LS2 9JT, UK.
Nick GilbertMedical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh EH4 1QY, UK.ORCID 0000-0003-0505-6081
Sébastien BrittonInstitut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), 31077 Toulouse Cedex 4, France.ORCID 0000-0002-7008-5316
Alan K MeekerDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Christopher M HeaphyDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Florence LarminatInstitut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), 31077 Toulouse Cedex 4, France.ORCID 0000-0002-3389-2717
Eric Van DyckDNA Repair and Chemoresistance Group, Department of Cancer Research, Luxembourg Institute of Health (LIH), L-1210 Luxembourg, Luxembourg.ORCID 0000-0001-8614-2402
Centre National de la Recherche Scientifique · FRLuxembourg Institute of Health · LUJohns Hopkins University · USInstitute of Genetics and Cancer · GBUniversity of Leeds · GBUniversity of Luxembourg · LUBoston University · US

Funding

ANR MEliCENDre -19-CE12- 0022BBSCR BB/V014358/1Fonds National de la Recherche du LuxembourgLIHNeuroendocrine Tumor Research FoundationTélévie/Fonds National de la Recherche 7.8510.21
6 · The paper itself

Abstract

Maintaining chromatin integrity at the repetitive non-coding DNA sequences underlying centromeres is crucial to prevent replicative stress, DNA breaks and genomic instability. The concerted action of transcriptional repressors, chromatin remodelling complexes and epigenetic factors controls transcription and chromatin structure in these regions. The histone chaperone complex ATRX/DAXX is involved in the establishment and maintenance of centromeric chromatin through the deposition of the histone variant H3.3. ATRX and DAXX have also evolved mutually-independent functions in transcription and chromatin dynamics. Here, using paediatric glioma and pancreatic neuroendocrine tumor cell lines, we identify a novel ATRX-independent function for DAXX in promoting genome stability by preventing transcription-associated R-loop accumulation and DNA double-strand break formation at centromeres. This function of DAXX required its interaction with histone H3.3 but was independent of H3.3 deposition and did not reflect a role in the repression of centromeric transcription. DAXX depletion mobilized BRCA1 at centromeres, in line with BRCA1 role in counteracting centromeric R-loop accumulation. Our results provide novel insights into the mechanisms protecting the human genome from chromosomal instability, as well as potential perspectives in the treatment of cancers with DAXX alterations.

Indexed as

CentromereDNA Breaks, Double-StrandedMolecular ChaperonesNuclear ProteinsR-Loop StructuresX-linked Nuclear ProteinAdaptor Proteins, Signal TransducingChildChromatinCo-Repressor ProteinsDNAHistonesHumansTranscription FactorsAdaptor Proteins, Signal TransducingATRX protein, humanChromatinCo-Repressor ProteinsDAXX protein, humanDNAHistonesMolecular ChaperonesNuclear ProteinsTranscription FactorsX-linked Nuclear Protein

Identifiers

PMID38038252
PMCPMC10853780
OpenAlexW4389242319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.